<DOC>
	<DOCNO>NCT02306083</DOCNO>
	<brief_summary>In double blind clinical trial 92 patient suffer rheumatoid arthritis include . Those history intraocular corneal surgery , diabetic heavy smoker exclude study . Before start treatment patient undergo complete ophthalmic exam , corneal biomechanical property assessment Ocular Response Analyzer ( ORA ) corneal thickness measurement . Patients randomly assign treatment placebo group . Those treatment group receive glucosamine sulfate 1500 mg three time day . Those placebo arm receive alike capsule schedule . At month 3 6 IOP ( intraocular pressure ) , ORA pachymetry would check .</brief_summary>
	<brief_title>Effect Glucosamine Intraocular Pressure</brief_title>
	<detailed_description />
	<criteria>History rheumatoid arthritis base ACR ( American College Rheumatology ) FC ( functional class ) . No history use drug test study . History kind corneal surgery . History intraocular surgery . History diabetes mellitus . Heavy smoker . Unwillingness participate study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>